Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

What else does weight-loss drug Ozempic do? 5 unexpected health benefits - Emerging scientific research indicates that ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and ...

Semaglutide (Ozempic ... a blood biomarker of Alzheimer’s improved in people who changed their lifestyle, but worsened in those who did not. The study involved only around 50 people, and ...

New research found that older individuals who visited the hospital for cannabis-related reasons could be at a higher risk of ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

A UF study finds that two common diabetes drugs may help protect against Alzheimer’s disease in older adults with Type 2 ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...